More than half of all US adults are eligible for semaglutide therapy, according to a research letter published online.

Lower noninvasive test cut-points are recommended among Hispanic adults with MASLD in order to optimize surveillance of fibrosis.

Low-FODMAP and gluten-free combined diets improve physical and psychological symptoms of irritable bowel syndrome.

Combination treatment with entinostat and nivolumab results in durable responses in a small subset of patients with advanced pancreatic ductal adenocarcinoma (PDA).

The risk for VTE was reduced among Military Health Systems beneficiaries who were vaccinated vs unvaccinated against COVID-19.

Suicide risk is not only elevated among individuals with psychiatric disorders, but also among individuals with medical conditions.

For patients with heart failure with preserved ejection fraction, tirzepatide yields a reduced risk for a composite of death from cardiovascular causes or worsening heart failure.

Digital health tools have the potential to improve health outcomes among individuals with IBS, but more research is needed.

Semaglutide and liraglutide are associated with a reduced risk for hospitalization due to alcohol use disorder (AUD).

Mortality risk, especially due to dermatological and endocrine causes, was higher among patients with type 1 diabetes compared with type 2 diabetes.

COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among adults so far this respiratory virus season (2024 to 2025).